Dopamine Uptake InhibitorsDopamine Plasma Membrane Transport ProteinsDopamineBenztropineTropanesNomifensineCorpus StriatumCocaineReceptors, Dopamine D2NortropanesMembrane Transport ProteinsDopamine AntagonistsNeurotransmitter Uptake InhibitorsPiperazinesReceptors, Dopamine D1PutamenReceptors, DopamineDopamine AgonistsMethamphetamineMazindolNeostriatumReceptors, Dopamine D3Tomography, Emission-Computed, Single-PhotonNerve Tissue ProteinsDopamine AgentsRacloprideMembrane GlycoproteinsOrganotechnetium CompoundsIodine RadioisotopesAmphetamineSynaptosomesParkinson DiseaseNorepinephrine Plasma Membrane Transport ProteinsRats, Sprague-DawleyRadiopharmaceuticals3,4-Dihydroxyphenylacetic AcidCaudate NucleusNucleus AccumbensMicrodialysisSubstantia NigraVesicular Monoamine Transport ProteinsAdrenergic Uptake InhibitorsMethylphenidateHomovanillic AcidTyrosine 3-MonooxygenaseMotor ActivityCarrier ProteinsReceptors, Dopamine D5SerotoninBehavior, AnimalSalicylamidesDose-Response Relationship, DrugOxidopamineDopaminergic NeuronsCentral Nervous System StimulantsBrainBiological TransportLevodopaQuinpiroleGABA Uptake InhibitorsSerotonin Plasma Membrane Transport Proteins1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineBiogenic MonoaminesMesencephalonTetrabenazineNeuronsParkinsonian DisordersBenzazepinesMembrane Transport ModulatorsMPTP PoisoningDopamine beta-HydroxylaseCocaine-Related DisordersParkinson Disease, SecondaryStereotyped BehaviorHaloperidolSerotonin Uptake InhibitorsBasal GangliaLobelinePositron-Emission TomographyATP-Binding Cassette TransportersFluoxetineBrain ChemistryNorepinephrineDesipramineSelf AdministrationNipecotic Acidsalpha-MethyltyrosineDextroamphetamineDrug Interactions1-Methyl-4-phenylpyridiniumDopamine and cAMP-Regulated Phosphoprotein 32ApomorphineDihydroxyphenylalanineZimeldinePyrrolidinesTime FactorsSulpirideMedial Forebrain BundleTritiumAntiparkinson Agents